Your browser is no longer supported. Please, upgrade your browser.
Settings
BIO Bio-Rad Laboratories, Inc. daily Stock Chart
BIO [NYSE]
Bio-Rad Laboratories, Inc.
Index- P/E11.65 EPS (ttm)28.12 Insider Own0.10% Shs Outstand30.33M Perf Week0.63%
Market Cap9.93B Forward P/E37.89 EPS next Y8.64 Insider Trans-4.65% Shs Float21.38M Perf Month5.62%
Income855.80M PEG0.58 EPS next Q1.46 Inst Own79.10% Short Float1.92% Perf Quarter10.37%
Sales2.29B P/S4.34 EPS this Y502.10% Inst Trans0.14% Short Ratio2.34 Perf Half Y21.14%
Book/sh184.03 P/B1.78 EPS next Y19.38% ROA13.50% Target Price385.00 Perf Year2.31%
Cash/sh32.37 P/C10.12 EPS next 5Y19.94% ROE18.80% 52W Range220.05 - 338.67 Perf YTD41.03%
Dividend- P/FCF40.74 EPS past 5Y31.20% ROI-6.60% 52W High-3.30% Beta1.19
Dividend %- Quick Ratio3.40 Sales past 5Y1.40% Gross Margin54.30% 52W Low48.83% ATR8.68
Employees8260 Current Ratio4.70 Sales Q/Q-0.60% Oper. Margin-3.50% RSI (14)55.33 Volatility2.69% 2.55%
OptionableYes Debt/Eq0.08 EPS Q/Q123.90% Profit Margin39.50% Rel Volume0.94 Prev Close319.13
ShortableYes LT Debt/Eq0.08 EarningsAug 01 AMC Payout0.00% Avg Volume175.12K Price327.50
Recom1.70 SMA202.16% SMA505.18% SMA20014.99% Volume164,278 Change2.62%
Oct-17-18Initiated Goldman Buy $350
Sep-20-18Initiated Morgan Stanley Equal-Weight $335
Feb-16-18Downgrade CL King Buy → Neutral
Jul-13-17Initiated Wells Fargo Outperform
Jun-28-17Upgrade Deutsche Bank Hold → Buy $220 → $255
Jan-18-17Initiated Deutsche Bank Hold $195
Oct-13-16Initiated CL King Buy
May-06-15Reiterated Jefferies Buy $150 → $165
Dec-18-09Initiated Maxim Group Buy $125
Nov-06-09Initiated Jefferies & Co Buy $130
Jul-17-09Initiated Soleil Buy $91
Sep-26-07Initiated Banc of America Sec Buy $110
Feb-23-07Downgrade Robert W. Baird Outperform → Neutral $83 → $76
Aug-13-19 07:00AM  The $200K Club: NetApp's median employee gets a pay boost to join the salary ranks of Google, Netflix and Facebook American City Business Journals
Aug-09-19 09:30AM  PRGO vs. BIO: Which Stock Is the Better Value Option? Zacks
Aug-02-19 09:15AM  Bio-Rad (Bio) Q2 Earnings Beat Estimates, Margins Expand Zacks +8.26%
Aug-01-19 08:26PM  Bio-Rad Laboratories Inc (BIO) (BIO-B) Q2 2019 Earnings Call Transcript Motley Fool
06:15PM  Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings and Revenue Estimates Zacks
04:15PM  Bio-Rad Reports Second-Quarter 2019 Financial Results Business Wire
Jul-30-19 12:20PM  Do Insiders Own Shares In Biome Grow Inc. (CNSX:BIO)? Simply Wall St.
Jul-25-19 10:33AM  Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-24-19 09:52PM  Delaware District Court Grants Bio-Rads Motion for Permanent Injunction Against 10X Genomics Business Wire
Jul-23-19 08:46PM  Bio-Rad to Report Second-Quarter 2019 Financial Results Business Wire
Jul-18-19 09:19AM  IVD Market Sustains Momentum: 3 Stocks in Focus Zacks
Jul-15-19 09:12AM  ABT or BIO: Which Stock Has Better Potential Right Now? Zacks
Jul-08-19 07:30AM  Facebook churns out a per-employee profit of $635K per year. How that compares with Apple, Google, Cisco, Oracle, Salesforce and others American City Business Journals
Jul-04-19 09:06AM  Here's Why You Should Invest in CONMED (CNMD) Stock Now Zacks
Jul-03-19 09:41AM  Luminex (LMNX) Presents ARIES MRSA Assay to FDA for Clearance Zacks
Jul-01-19 05:43PM  Bio-Rad Laboratories, Inc. -- Moody's announces completion of a periodic review of ratings of Bio-Rad Laboratories, Inc. Moody's
Jun-27-19 07:34PM  Moodys Upgrades Bio-Rad to Baa2, Reflecting Recent Improvement in the Companys Operating Performance Business Wire
03:35PM  Bio-Rad Laboratories, Inc. -- Moody's upgrades Bio-Rad to Baa2, outlook is stable Moody's
Jun-14-19 08:29AM  Heres What Hedge Funds Think About Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
06:53AM  What Kind Of Shareholder Appears On The BIOTON S.A.'s (WSE:BIO) Shareholder Register? Simply Wall St.
Jun-12-19 07:30AM  9 major Bay Area tech employers pay a typical worker more than $200K per year American City Business Journals
Jun-07-19 09:30AM  Bio-Rad (BIO) Down 6.9% Since Last Earnings Report: Can It Rebound? Zacks
Jun-03-19 02:03PM  Bio-Rad to Participate in Goldman Sachs Annual Global Healthcare Conference on June 11 Business Wire
May-31-19 08:09AM  Here's Why You Should Retain Bio-Rad (BIO) Stock For Now Zacks
May-24-19 12:00PM  When Will Biome Grow Inc. (CNSX:BIO) Become Profitable? Simply Wall St.
May-23-19 04:09PM  Bio-Rad to Participate at Jefferies 2019 Global Healthcare Conference on June 4 Business Wire
May-17-19 08:18AM  Edited Transcript of BIO earnings conference call or presentation 8-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-09-19 09:03AM  Bio-Rad (BIO) Q1 Earnings Beat Estimates, Margins Expand Zacks
May-08-19 08:23PM  Bio-Rad Laboratories Inc (BIO) Q1 2019 Earnings Call Transcript Motley Fool
07:05PM  Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Beat Estimates Zacks
06:00PM  Bio-Rad: 1Q Earnings Snapshot Associated Press
04:15PM  Bio-Rad Reports First Quarter 2019 Financial Results Business Wire
May-07-19 10:38AM  Will Life Sciences Sales Boost Bio-Rad's (BIO) Q1 Earnings? Zacks
07:30AM  Netflix and Google now pay a typical employee more than $200K per year. Here's how that compares to Facebook, Intel, Twitter and other big Bay Area tech employers. American City Business Journals
May-01-19 10:33AM  Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-25-19 12:05PM  CONMED (CNMD) Beats on Q1 Earnings, Raises '19 Guidance Zacks
11:20AM  Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates Zacks
04:10AM  Edwards Lifesciences (EW) Q1 Earnings Beat, EPS View Raised Zacks
Apr-24-19 11:37AM  Boston Scientific (BSX) Misses Q1 Earnings, Tightens EPS View Zacks
11:35AM  Thermo Fisher (TMO) Beats on Q1 Earnings, Raises '19 View Zacks
10:40AM  Accuray (ARAY) Q3 Earnings Top Estimates, Gross Orders Rise Zacks
10:23AM  Merit Medical (MMSI) Q1 Earnings & Revenues Beat Estimates Zacks
10:11AM  Stryker (SYK) Q1 Earnings Beat Estimates, Revenues In Line Zacks
Apr-23-19 04:15PM  Bio-Rad to Participate in the Bank of America Merrill Lynch Health Care Conference 2019 in May Business Wire
10:58AM  Quest Diagnostics (DGX) Q1 Earnings Top Mark, Margins Down Zacks
Apr-22-19 05:00PM  Bio-Rad Appoints Andrew Last as Executive Vice President and Chief Operating Officer Business Wire
Apr-20-19 01:02PM  Is Bio-Rad Laboratories, Inc. (BIO) A Good Stock To Buy? Insider Monkey
Apr-17-19 11:54AM  Abbott (ABT) Q1 Earnings Beat Estimates, Organic Sales Solid Zacks
Apr-15-19 07:03PM  Bio-Rad to Report First-Quarter 2019 Financial Results Business Wire
Apr-12-19 09:45AM  Weekly Jobless Claims Lowest in Nearly 50 Years: 5 Top Picks Zacks
Apr-10-19 07:25AM  FireEye joins major Bay Area employers like Facebook, Netflix, Google, Microsoft and Salesforce in paying a typical worker more than $150,000 per year American City Business Journals
Apr-09-19 09:13AM  Bio-Rad's (BIO) IH-500 System Secures 510(K) From the FDA Zacks
07:30AM  Dow Jones Futures: Zogenix Leads 3 Big Movers On FDA News Investor's Business Daily
Apr-08-19 04:15PM  Bio-Rad Receives U.S. FDA Clearance for the IH-500, Expanding Its Offering for the Blood Testing Market Business Wire
Apr-03-19 09:10AM  Bio-Rad's Latest FDA Nod to Boost Clinical Diagnostics Arm Zacks
Apr-02-19 05:00PM  Bio-Rad Names Ilan Daskal Executive Vice President and Chief Financial Officer Business Wire
09:56AM  Elon Musks CEO pay-to-worker ratio is the highest ever recorded how it compares at other tech companies American City Business Journals
08:30AM  Bio-Rad Announces Innovative Test to Aid in the Diagnosis of Lyme Disease with the FDA Clearance of the BioPlex 2200 Lyme Total Assay Business Wire
Mar-30-19 09:30AM  Why Is Bio-Rad (BIO) Up 12.8% Since Last Earnings Report? Zacks
Mar-27-19 07:25AM  Recent Analysis Shows Transocean, Chipotle Mexican Grill, Marathon Oil, Laboratory Corporation of America, Bio-Rad Laboratories, and Graco Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Mar-25-19 05:00PM  Bio-Rad Laboratories, Inc. Receives Expected NYSE Notice Regarding Late Form 10-K Filing Business Wire
Mar-22-19 08:41AM  GBT Reports Fourth Quarter and 2018 Results PR Newswire
Mar-21-19 10:25AM  Top Ranked Momentum Stocks to Buy for March 21st Zacks
Mar-15-19 10:03AM  Here's Why You Should Buy Masimo (MASI) Stock Right Now Zacks
09:38AM  Looking for a Growth Stock? Why It is Time to Focus on Bio-Rad (BIO) Zacks
08:31AM  BD's Venovo Gets FDA Nod, Interventional Arm to Get a Boost Zacks
Mar-14-19 08:38AM  Here's Why You Should Invest in Stryker (SYK) Stock Right Now Zacks
08:36AM  HEXO Catches Eye: Stock Jumps 6.6% Zacks
Mar-12-19 08:45AM  Here is Why Growth Investors Should Buy Bio-Rad (BIO) Now Zacks
06:35AM  Will Bio-Rad Laboratories Continue to Surge Higher? Zacks
Mar-11-19 09:15AM  Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Zacks
Mar-06-19 10:12AM  What Makes Bio-Rad (BIO) a New Strong Buy Stock Zacks
Mar-05-19 10:02PM  Edited Transcript of BIO earnings conference call or presentation 28-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
07:30AM  The $200K Club: Broadcom joins these Bay Area tech companies paying a typical employee top dollar American City Business Journals
Mar-01-19 08:50AM  The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis Benzinga +17.17%
07:51AM  Bio-Rad (BIO) Earnings and Revenues Beat Estimates in Q4 Zacks
Feb-28-19 04:38PM  Bio-Rad Reports Fourth-Quarter and Full-Year 2018 Financial Results Business Wire
01:30PM  Is Bio-Rad Laboratories, Inc. (NYSE:BIO) A Financially Strong Company? Simply Wall St.
Feb-21-19 10:31AM  Bio-Rad Laboratories (BIO) Reports Next Week: Wall Street Expects Earnings Growth Zacks
08:55AM  Will Difficult Comparison Hurt Bio-Rad's (BIO) Q4 Earnings? Zacks
Feb-15-19 07:30AM  The typical Facebook employee earns double Silicon Valley's median household income. How 50+ big tech employers compare American City Business Journals
Feb-14-19 07:28PM  Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response Business Wire
Feb-12-19 06:31PM  Bio-Rad to Report Fourth-Quarter and Full-Year 2018 Financial Results Thursday, February 28, 2019 Business Wire
Feb-04-19 07:50AM  Report: Developing Opportunities within T-Mobile US, Noble, Akebia Therapeutics, Vornado Realty Trust, Bio-Rad Laboratories, and Standex International Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-29-19 10:14AM  Bio-Rad Laboratories, Inc. (NYSE:BIO): A Fundamentally Attractive Investment Simply Wall St.
Jan-15-19 07:30AM  This is how much Apple pays a typical employee and how that compares to Google, Facebook, Netflix, Microsoft, Box and more American City Business Journals
Jan-03-19 04:30PM  Christine Tsingos Announces Plans to Retire as CFO of Bio-Rad Laboratories, Inc. Effective April 30, 2019 Business Wire
09:10AM  Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M Zacks
Jan-02-19 06:10PM  Bio-Rad to Participate at the 37th Annual J.P. Morgan Healthcare Conference on January 8 Business Wire
Dec-09-18 03:00AM  Hedge Funds Are Crazy About Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Dec-03-18 08:30AM  Bio-Rad Quality Controls Now Available for Multiple Abbott Clinical Diagnostics Platforms Business Wire
Nov-30-18 08:25AM  New Research Coverage Highlights Omeros, Apple, Bio-Rad Laboratories, Cott, Darling Ingredients, and Osisko Gold Royalties Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-14-18 08:55AM  Bio-Rad Clinches USDA Contract, Boosts Life Science Segment Zacks
08:30AM  Bio-Rad and the University of Chicago Win Patent Infringement Case Against 10X Genomics Related to Droplet Microfluidics Technologies Business Wire
Nov-13-18 08:30AM  Bio-Rad Wins USDA Contract for Its Pathogen Detection Testing Products Business Wire
Nov-12-18 10:07PM  GBT Reports Third Quarter And 9M18 Results PR Newswire
Nov-03-18 06:16PM  Edited Transcript of BIO earnings conference call or presentation 1-Nov-18 9:00pm GMT Thomson Reuters StreetEvents
Nov-02-18 10:50AM  Bio-Rad (BIO) Earnings Miss Estimates in Q3, Revenues Beat Zacks
05:12AM  Bio-Rad: 3Q Earnings Snapshot Associated Press
Nov-01-18 09:25PM  Bio-Rad Laboratories Inc (BIO) Q3 2018 Earnings Conference Call Transcript Motley Fool
Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the Pacific Rim, the United States, and internationally. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ERNST TIMOTHY SEVP, General Counsel & SecAug 14Sale320.0031099,200103Aug 14 05:51 PM
Crowley MichaelEVP, GBL Commercial OperationsAug 14Sale320.00325104,0003,100Aug 14 05:46 PM
ERNST TIMOTHY SEVP, General Counsel & SecMay 16Sale299.24501149,837390May 16 07:01 PM
Magni GiovanniEVP, Chief Strategy OfficerMay 15Option Exercise74.273,500259,94515,420May 15 07:03 PM
ERNST TIMOTHY SEVP, General Counsel & SecMay 15Sale290.00345100,050891May 16 07:01 PM
SCHWARTZ NORMAN DChairman, President and CEOMay 13Option Exercise75.3837,0002,789,060298,642May 13 08:12 PM
Crowley MichaelEVP, GBL Commercial OperationsDec 14Sale248.0339297,2283,425Dec 14 07:00 PM
TSINGOS CHRISTINE AEVP and CFODec 14Sale248.001,411349,9286,683Dec 17 11:20 AM
STARK JAMES RVP, Corporate ControllerDec 12Sale254.77848216,0450Dec 12 05:16 PM
TUMOLO ANNETTEExecutive Vice PresidentDec 11Option Exercise159.321,200191,1842,704Dec 12 05:07 PM
TUMOLO ANNETTEExecutive Vice PresidentDec 11Sale254.512,376604,7041,504Dec 12 05:07 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 11Option Exercise0.001,00003,027Sep 13 04:38 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 11Option Exercise0.005,8000264,465Sep 13 04:22 PM
TSINGOS CHRISTINE AEVP and CFOSep 11Option Exercise0.0066008,323Sep 13 04:17 PM
STARK JAMES RVP, Corporate ControllerSep 11Option Exercise0.0050001,022Sep 13 04:13 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 11Option Exercise0.00740012,287Sep 13 04:08 PM
HUTTON RONALD WVice President and TreasurerSep 11Option Exercise0.0030004,104Sep 13 04:01 PM
HERTIA JOHNExecutive Vice PresidentSep 11Option Exercise0.001,300015,038Sep 13 03:57 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 11Option Exercise0.0097604,156Sep 13 03:53 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 10Option Exercise0.0038903,315Sep 12 05:10 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 10Option Exercise0.0040002,166Sep 12 05:06 PM
TSINGOS CHRISTINE AEVP and CFOSep 10Option Exercise0.0040007,802Sep 12 05:00 PM
STARK JAMES RVP, Corporate ControllerSep 10Option Exercise0.002000592Sep 12 04:55 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 10Option Exercise0.00400011,746Sep 12 04:51 PM
HUTTON RONALD WVice President and TreasurerSep 10Option Exercise0.0015003,856Sep 12 04:48 PM
HERTIA JOHNExecutive Vice PresidentSep 10Option Exercise0.00600013,946Sep 12 04:10 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 10Option Exercise0.002,0000259,657Sep 12 07:39 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 08Option Exercise0.00400011,545Sep 11 02:28 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 07Option Exercise0.0060001,974Sep 11 02:46 PM
TSINGOS CHRISTINE AEVP and CFOSep 07Option Exercise0.0050007,575Sep 11 02:43 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 07Option Exercise0.003,0000259,145Sep 11 02:38 PM
STARK JAMES RVP, Corporate ControllerSep 07Option Exercise0.003000496Sep 11 02:33 PM
HUTTON RONALD WVice President and TreasurerSep 07Option Exercise0.0017003,765Sep 11 02:20 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 07Option Exercise0.0050001,372Sep 11 01:42 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 07Option Exercise0.0060003,134Sep 11 01:28 PM
HERTIA JOHNExecutive Vice PresidentSep 07Option Exercise0.00600013,554Sep 11 02:02 PM
HERTIA JOHNExecutive Vice PresidentSep 05Option Exercise0.00600013,162Sep 07 02:43 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 05Option Exercise0.0060001,582Sep 07 02:41 PM
TSINGOS CHRISTINE AEVP and CFOSep 05Option Exercise0.0060007,283Sep 06 08:12 PM
STARK JAMES RVP, Corporate ControllerSep 05Option Exercise0.003000300Sep 06 08:08 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 05Option Exercise0.002,6000413,852Sep 06 08:05 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 05Option Exercise0.00500011,333Sep 06 08:02 PM
HUTTON RONALD WVice President and TreasurerSep 05Option Exercise0.0018003,658Sep 06 08:00 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 05Option Exercise0.0050001,045Sep 06 07:57 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 05Option Exercise0.0060002,742Sep 06 07:53 PM